EPCAM deletion carriers constitute a unique subgroup of Lynch syndrome patients

Keyphrases

• Lynch Syndrome 100%
• Epithelial Cell Adhesion Molecule (EpCAM) 100%
• MSH2 30%
• 3' End 20%
• Mutation Carriers 20%
• MSH2 Gene 20%
• Clinically Significant 10%
• Colorectal Cancer Risk 10%
• Germ Cells 10%
• Cancer Susceptibility Syndrome 10%
• Depth Assessment 10%
• Promoter Methylation 10%
• Polyadenylation Signal 10%
• Upstream Open Reading Frame (uORF) 10%
• Epimutation 10%
• Actual Risk 10%
• PMS2 10%
• Cell Lineage 10%
• Colorectal Cancer Stem Cells 10%
• EPCAM Gene 10%
• Dordrecht 10%
• MLH1 10%
• Germline mutation 10%
• Genotype-phenotype Correlation 10%
• Hypermethylation 10%
• Endometrial Cancer 10%
• Business Media 10%
• Common Cancers 10%
• Molecular Mechanism 10%
• Transcriptional Read-through 10%
• High-level Expression 10%
• Mismatch Repair Proteins 10%
• MSH6 10%

Biochemistry, Genetics and Molecular Biology

• MSH2 100%
• Promoter Region 33%
• Germline 16%
• MLH1 16%
• Methylation 16%
• Germ Cell 16%
• DNA Mismatch Repair 16%
• Polyadenylation 16%
• Germline Mutation 16%
• Allele 16%
• Epimutation 16%
• Genotype Phenotype Correlation 16%
• Cancer Stem Cell 16%
• PMS2 16%
• Cell Lineage 16%
• Open Reading Frame 16%
• MSH6 16%